Baseline characteristics

A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate · Source last updated 2013-10-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      318

   2. group Id

      BG001

      value

      157

   3. group Id

      BG002

      value

      475

   units

   Participants

groups

1. description

   1000 mg rituximab intravenous initial treatment on day 1 and day 15 plus 10-25 mg/week methotrexate followed by re-treatment during weeks 24 -40 consisting of two additional doses of 1000 mg rituximab 14 days apart plus 10-25 mg/week methotrexate.

   id

   BG000

   title

   Arm A: Rituximab Retreatment

2. description

   1000 mg rituximab initial treatment on day 1 and day 15 plus 10-25 mg/wk methotrexate followed by re-treatment during weeks 24 -40 consisting of two doses of placebo 14 days apart plus 10-25 mg/wk methotrexate.

   id

   BG001

   title

   Arm B: Placebo Retreatment

3. description

   Total of all reporting groups

   id

   BG002

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            0

         2. group Id

            BG001

            value

            0

         3. group Id

            BG002

            value

            0

         title

         <=18 years

      2. measurements

         1. group Id

            BG000

            value

            266

         2. group Id

            BG001

            value

            133

         3. group Id

            BG002

            value

            399

         title

         Between 18 and 65 years

      3. measurements

         1. group Id

            BG000

            value

            52

         2. group Id

            BG001

            value

            24

         3. group Id

            BG002

            value

            76

         title

         >=65 years

   description

   Baseline measures are based on the Intent-to-treat population that includes all participants randomized to Retreatment.

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Age, Categorical

   unit Of Measure

   Participants

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            10.57

            value

            54.2

         2. group Id

            BG001

            spread

            10.52

            value

            53.9

         3. group Id

            BG002

            spread

            10.54

            value

            54.1

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age Continuous

   unit Of Measure

   years

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            257

         2. group Id

            BG001

            value

            124

         3. group Id

            BG002

            value

            381

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            61

         2. group Id

            BG001

            value

            33

         3. group Id

            BG002

            value

            94

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice